US Patent Issued to Roche Glycart on April 29 for "Anti-FAP antibodies and methods of use" (Swiss Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,286,486, issued on April 29, was assigned to Roche Glycart AG (Switzerland).

"Anti-FAP antibodies and methods of use" was invented by Marina Bacac (Lausanne, Switzerland), Anne Freimoser-Grundschober (Zurich), Ralf Hosse (Cham, Switzerland), Christian Klein (Bonstetten, Switzerland), Ekkehard Moessner (Kreuzlingen, Switzerland), Valeria G. Nicolini (Erlenbach, Switzerland) and Pablo Umana (Waedenswil, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides antibodies against Fibroblast Activation Protein (FAP) and methods of using the same."

The patent was filed on May 13, 2022, under Application No. 17/663,396.

*For further i...